Hasil Pencarian - Hurvitz SA

  • Menampilkan 1 - 3 hasil dari 3
Perbaiki Hasil
  1. 1
    Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer

    Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer oleh Hurvitz SA, Kakkar R

    Diterbitkan 2012-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Profiling and targeting HER2-positive breast cancer using trastuzumab emtansine

    Profiling and targeting HER2-positive breast cancer using trastuzumab emtansine oleh Sadeghi S, Olevsky O, Hurvitz SA

    Diterbitkan 2014-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2− Advanced Breast Cancer

    Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2− Advanced Breast Cancer oleh Fasching PA, Delea TE, Lu YS, De Boer R, Hurvitz SA, Moynahan A, Chandiwana D, Lanoue B, Hu H, Thuerigen A, O'Shaughnessy J

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: